Clinical Development Lead, Solid Tumor Oncology, BTC & GEA

Jazz Pharmaceuticals - Clinical Development Lead, Solid Tumor Oncology, BTC & GEA

Jazz Pharmaceuticals is seeking a Clinical Development Lead for Solid Tumor Oncology in the BTC (Biliary Tract Cancer) and GEA (Gastroesophageal Adenocarcinoma) areas. This key role involves driving the strategy and execution of late-stage development programs, managing cross-functional teams, ensuring regulatory compliance, and fostering a culture of excellence in clinical development.

Responsibilities

• Provide strategic leadership for the clinical development of Solid Tumor Oncology assets in BTC and GEA.
• Develop and execute global clinical development plans, including study design and regulatory strategy.
• Collaborate with various departments to ensure smooth execution of clinical programs.
• Oversee clinical trials, data analysis, risk management, and external partnerships.
• Manage budget, resources, and team development to achieve positive patient outcomes.

Requirements

• Demonstrable experience in leading successful Solid Tumor Oncology asset development.
• Proven track record in leading high-performance clinical development teams.
• Strong executive presence and ability to communicate complex insights effectively.
• MD required, Board certified Oncologist preferred.
• Higher postgraduate degree preferred.

Benefits

• Market-competitive compensation.
• Comprehensive benefits package.
• Opportunities for professional growth and development.
• Equal opportunity employer with a commitment to fair compensation practices.